Purchase Order HHSN272201000146P
Award Date 12/4/09
Potential Completion Date 1/15/10
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Other
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases Division of Acquisitions awarded a purchase order contract valued at approximately $6,200 to Bio Basic Canada Inc. for gene synthesis services. Under contract number NIH102-1, Bio Basic will provide 15,292 units of gene synthesis at $0.39 per unit to the NIH NIAID DEA OA located in Bethesda, Maryland. The contract period of performance spans from December 9, 2009...
- <p>This is a $23,549.66 purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Bio Basic Canada Inc. The contract is for the purchase of synthetic DNA related to respiratory syncytial virus (RSV) research. The contract has a completion date of September 16, 2010 and was awarded on August 17, 2010. This contract is not associated with a set-aside program.</p>
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- This federal contract award, with ID HHSN272201200181P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services (HHS). The $3,528.90 Firm Fixed Price contract was awarded to Bio Basic Canada Inc. on January 25, 2012 for the delivery of 1,200 units of synthetic genes related to the nucleoprotein of the Human Metapneumovirus (HMPV) at a unit price of $0.30, for a total of $360.00. The contract has an ultimate completion...
- This federal contract award to Genscript USA Inc. is for $182,897.61 to provide custom gene synthesis services to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is a firm fixed-price purchase order with no set-aside designation, and the services include DNA synthesis, subcloning, and plasmid preparation to support HIV research being conducted at the NIH...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, is for $20,000.00 in custom gene synthesis and expression services provided by Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. While the original solicitation is not provided, the award likely...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Geneuniversal Inc., a for-profit biotechnology company, for gene synthesis services. The contract has a potential value of $148,279.20 and does not have a set-aside designation. The work will be performed out of Newark, Delaware and is likely to support NIH's infectious disease research efforts....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for gene synthesis services. The $17,000.35 contract has a completion date of December 30, 2020 and was awarded on December 31, 2019. The services provided under this contract supported biomedical research and public health initiatives carried out by the agency. Genscript has...